Accepted abstracts are made available to the public on the ACR Web site and are published in a special supplement of Arthritis & Rheumatism in advance of the meeting. Information contained in those abstracts may not be released until the abstracts appear on the ACR Web site.

Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR Web site.

However, the ACR continues to require that information that goes beyond that contained in the abstract, e.g., discussion of the abstract done as part of a scientific presentation or presentation of additional new information that will be available at the time of the meeting, is under embargo until 5:00 PM Pacific Time (8:00 PM Eastern Time) on Saturday, October 25. Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate.

It is not considered a violation of this policy if the information contained in the abstract is presented at another meeting, if acceptance is still pending at the time of the abstract submission deadline, or if the abstract is published in a peer reviewed journal after the abstract submission deadline.

Authors are responsible for notifying financial and other sponsors about this policy.

The two exceptions to this embargo policy is that the abstracts presented at the ACR Basic Research Conference and the ACR Clinical Research Conference are under embargo until 8:30 AM Pacific Time (11:30 AM Eastern Time) on Friday, October 24.

Back to Newsroom General Information